Gamco Investors INC. ET AL Boosts Position in Kindred Healthcare, Inc. (KND)

Gamco Investors INC. ET AL increased its position in Kindred Healthcare, Inc. (NYSE:KND) by 6.2% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 458,446 shares of the health services provider’s stock after purchasing an additional 26,700 shares during the period. Gamco Investors INC. ET AL owned 0.53% of Kindred Healthcare worth $3,117,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Janus Henderson Group PLC acquired a new position in Kindred Healthcare in the second quarter worth about $130,000. Amalgamated Bank grew its stake in Kindred Healthcare by 0.9% in the second quarter. Amalgamated Bank now owns 11,518 shares of the health services provider’s stock worth $134,000 after purchasing an additional 108 shares in the last quarter. Paloma Partners Management Co acquired a new position in Kindred Healthcare in the first quarter worth about $133,000. State of Alaska Department of Revenue grew its stake in Kindred Healthcare by 80.0% in the second quarter. State of Alaska Department of Revenue now owns 16,916 shares of the health services provider’s stock worth $197,000 after purchasing an additional 7,516 shares in the last quarter. Finally, Piedmont Investment Advisors LLC acquired a new position in Kindred Healthcare in the second quarter worth about $216,000. Institutional investors and hedge funds own 87.08% of the company’s stock.

Kindred Healthcare, Inc. (KND) opened at $7.50 on Monday. The company has a quick ratio of 1.53, a current ratio of 1.55 and a debt-to-equity ratio of 6.22. Kindred Healthcare, Inc. has a 52 week low of $5.50 and a 52 week high of $11.90. The company has a market capitalization of $651.99, a P/E ratio of 37.50 and a beta of 1.12.

Kindred Healthcare (NYSE:KND) last issued its earnings results on Monday, November 6th. The health services provider reported ($0.11) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.19) by $0.08. Kindred Healthcare had a positive return on equity of 2.29% and a negative net margin of 8.06%. The company had revenue of $1.48 billion during the quarter, compared to the consensus estimate of $1.44 billion. During the same period in the previous year, the firm posted $0.05 earnings per share. Kindred Healthcare’s quarterly revenue was down 5.5% compared to the same quarter last year. equities research analysts predict that Kindred Healthcare, Inc. will post 0.29 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “Gamco Investors INC. ET AL Boosts Position in Kindred Healthcare, Inc. (KND)” was originally reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this article on another website, it was illegally stolen and republished in violation of U.S. and international copyright law. The legal version of this article can be viewed at https://ledgergazette.com/2017/11/13/gamco-investors-inc-et-al-boosts-position-in-kindred-healthcare-inc-knd.html.

KND has been the subject of a number of research reports. BidaskClub downgraded Kindred Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, July 31st. Deutsche Bank AG decreased their target price on Kindred Healthcare from $13.00 to $10.00 and set a “buy” rating for the company in a research note on Monday, August 7th. Zacks Investment Research upgraded Kindred Healthcare from a “sell” rating to a “hold” rating in a research note on Friday, August 11th. Royal Bank Of Canada decreased their target price on Kindred Healthcare from $9.00 to $7.50 and set a “sector perform” rating for the company in a research note on Thursday, September 21st. Finally, Bank of America Corporation decreased their target price on Kindred Healthcare from $7.50 to $6.50 and set an “underperform” rating for the company in a research note on Thursday, September 21st. Three research analysts have rated the stock with a sell rating, five have assigned a hold rating and one has issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $9.17.

Kindred Healthcare Profile

Kindred Healthcare, Inc, incorporated on March 27, 1998, is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.

Institutional Ownership by Quarter for Kindred Healthcare (NYSE:KND)

Receive News & Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply